Literature DB >> 22522680

Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production.

Stephen T Cartman1, Michelle L Kelly, Daniela Heeg, John T Heap, Nigel P Minton.   

Abstract

Clostridium difficile causes a potentially fatal diarrheal disease through the production of its principal virulence factors, toxin A and toxin B. The tcdC gene is thought to encode a negative regulator of toxin production. Therefore, increased toxin production, and hence increased virulence, is often inferred in strains with an aberrant tcdC genotype. This report describes the first allele exchange system for precise genetic manipulation of C. difficile, using the codA gene of Escherichia coli as a heterologous counterselection marker. It was used to systematically restore the Δ117 frameshift mutation and the 18-nucleotide deletion that occur naturally in the tcdC gene of C. difficile R20291 (PCR ribotype 027). In addition, the naturally intact tcdC gene of C. difficile 630 (PCR ribotype 012) was deleted and then subsequently restored with a silent nucleotide substitution, or "watermark," so the resulting strain was distinguishable from the wild type. Intriguingly, there was no association between the tcdC genotype and toxin production in either C. difficile R20291 or C. difficile 630. Therefore, an aberrant tcdC genotype does not provide a broadly applicable rationale for the perceived notion that PCR ribotype 027 strains are "high-level" toxin producers. This may well explain why several studies have reported that an aberrant tcdC gene does not predict increased toxin production or, indeed, increased virulence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522680      PMCID: PMC3370502          DOI: 10.1128/AEM.00249-12

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  40 in total

1.  Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom.

Authors:  Vhairi Wilson; Liz Cheek; Giovanni Satta; Karen Walker-Bone; Marc Cubbon; Diane Citron; Dale N Gerding; Martin J Llewelyn
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

2.  Development and application of a method for counterselectable in-frame deletion in Clostridium perfringens.

Authors:  Hirofumi Nariya; Shigeru Miyata; Motoo Suzuki; Eiji Tamai; Akinobu Okabe
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

3.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

4.  A modular system for Clostridium shuttle plasmids.

Authors:  John T Heap; Oliver J Pennington; Stephen T Cartman; Nigel P Minton
Journal:  J Microbiol Methods       Date:  2009-05-13       Impact factor: 2.363

Review 5.  Fluorinated pyrimidines and their nucleosides.

Authors:  C Heidelberger; P V Danenberg; R G Moran
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1983

6.  A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile.

Authors:  Stephen T Cartman; Nigel P Minton
Journal:  Appl Environ Microbiol       Date:  2009-12-18       Impact factor: 4.792

7.  Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.

Authors:  N Esther Babady; Jeffrey Stiles; Phyllis Ruggiero; Perminder Khosa; David Huang; Susan Shuptar; Mini Kamboj; Timothy E Kiehn
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

8.  The ClosTron: Mutagenesis in Clostridium refined and streamlined.

Authors:  John T Heap; Sarah A Kuehne; Muhammad Ehsaan; Stephen T Cartman; Clare M Cooksley; Jamie C Scott; Nigel P Minton
Journal:  J Microbiol Methods       Date:  2009-11-03       Impact factor: 2.363

9.  Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting.

Authors:  Jeffrey Cloud; Laura Noddin; Amanda Pressman; Mary Hu; Ciaran Kelly
Journal:  Clin Gastroenterol Hepatol       Date:  2009-05-22       Impact factor: 11.382

10.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

View more
  109 in total

Review 1.  Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection.

Authors:  L Patrick Schenck; Paul L Beck; Justin A MacDonald
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

2.  Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

Authors:  T Pilate; J Verhaegen; M Van Ranst; V Saegeman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-08       Impact factor: 3.267

3.  Regulation and Anaerobic Function of the Clostridioides difficile β-Lactamase.

Authors:  Brindar K Sandhu; Adrianne N Edwards; Sarah E Anderson; Emily C Woods; Shonna M McBride
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  Clostridium difficile infection in older adults.

Authors:  Robin Lp Jump
Journal:  Aging health       Date:  2013-08-01

Review 5.  CRISPR Genome Editing Systems in the Genus Clostridium: a Timely Advancement.

Authors:  Kathleen N McAllister; Joseph A Sorg
Journal:  J Bacteriol       Date:  2019-07-24       Impact factor: 3.490

6.  A novel subtyping assay for detection of Clostridium difficile virulence genes.

Authors:  Stephanie L Angione; Aartik A Sarma; Aleksey Novikov; Leah Seward; Jennifer H Fieber; Leonard A Mermel; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2014-01-13       Impact factor: 5.568

Review 7.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

Review 8.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

9.  The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.

Authors:  Ana M Oliveira Paiva; Leen de Jong; Annemieke H Friggen; Wiep Klaas Smits; Jeroen Corver
Journal:  J Bacteriol       Date:  2020-10-22       Impact factor: 3.490

10.  Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile.

Authors:  Erika van Eijk; Ilse M Boekhoud; Ed J Kuijper; Ingrid M J G Bos-Sanders; George Wright; Wiep Klaas Smits
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.